July 22nd, 2022
12:00 PM Pacific
Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions. Click here to learn more about Harmony Biosciences.
Learn more about their ongoing clinical trial, Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1.
Presenters to be announced.
Click here to find all our upcoming Meet the DM Drug Developers dates!
Date(s)